Virogin Biotech
Manufacturing · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
3800 Wesbrook Mall, Vancouver, British C...Phone Number
(604) 222-0591Website
www.virogin.comRevenue
$10.6 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About Virogin Biotech
Virogin Biotech is a oncolytic virus company that creates impactful drugs for patients of highest medical need. Established in 2015, Virogin Biotech is headquartered in British Columbia, Canada.Explore more
Virogin Biotech Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Virogin Biotech your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Virogin Biotech has new funding data
Virogin Biotech, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Virogin Biotech had a recent Job posting/layoffs
Check if Virogin Biotech has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Virogin Biotech
Check out if Virogin Biotech is spiking on competitors!
Earning: See what the market has to say on Virogin Biotech recently announced quarterly report
Product Launch: Get notified when Virogin Biotech launches new products
Recommended Actions
Find VP level buyers at Virogin Biotech
Find more new buyers
Compare Similar Companies to Virogin Biotech
Compare insights from companies similar to Virogin Biotech, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Virogin Biotech is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Virogin Biotech is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Virogin Biotech.
Virogin Biotech financials insights
Gather financial insights about Virogin Biotech, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Series A
$5M
2020
Series C
$62M
Virogin Biotech Tech Stack
A closer look at the technologies used by Virogin Biotech
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Open Position
Virogin Biotech is currently seeking a Head Of Regulatory Affairs. (Seattle, WA)
New Hire
Executive Move
Huanyu Zhao has been named Vice President, Business Development. Previously, Zhao served as Manager, Business at Livzon Pharmaceutical Group Co., Ltd..
Funding
Virogin Biotech News & Media
Virogin Biotech Announces Dosing the First US Patient in a Phase 1 Study of VG201 for Patients With Advanced Solid Tumors
VANCOUVER, British Columbia, Nov. 15, 2022 (GLOBE NEWSWIRE) -- Virogin Biotech, a clinical-stage biotech company, today announced that the first patient has been dosed in its Phase 1 clinical study evaluating VG201, a first-in-class HSV Type I oncolytic virus product constructed based on a transcriptional and translational dual-regulated (TTDR) backbone developed by Virogin Biotech. It is designed to generate enhanced oncolytic activity specifically for tumors expressing carcinoembryonic antigenVirogin Biotech and MD Anderson Announce Strategic Collaboration to Accelerate Oncolytic Virus Research and Development for Treating Advanced Cancers
Virogin Biotech, a clinical-stage biotech company, and The University of Texas MD Anderson Cancer Center today announced a strategic collaboratio ...CDH, CMG-SDIC fund co-lead $62m Series C round in Virogin Biotech
Seoul-based Korea Investment Partners (KIP), Panlin Capital, Linden Asset, Xiaoxi Holdings, and Peking University Alumni (Canada), also participated.
Read more news
Top Manufacturing Companies
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Virogin Biotech
Sign Up For FreeTo access detailed company insights
Virogin Biotech is a oncolytic virus company that creates impactful drugs for patients of highest medical need. Established in 2015, Virogin Biotech is headquartered in British Columbia, Canada.... Read More
